BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |